Roivant Sciences (ROIV) Non-Current Debt (2021 - 2024)

Roivant Sciences (ROIV) has reported Non-Current Debt for 4 consecutive years, with $311.7 million the latest figure, recorded in Q2 2024.

• For the quarter ending Q2 2024, Non-Current Debt fell 19.05% year-over-year to $311.7 million; the trailing twelve-month figure through Jun 2024 stood at $311.7 million (down 19.05% YoY), and the FY2024 full-year result was $430.6 million, up 14.67% from the prior year.
• Non-Current Debt fell to $311.7 million in Q2 2024 per ROIV's latest filing, from $430.6 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $430.6 million in Q1 2024 and bottomed at $170.3 million in Q1 2021.
• Historically, Non-Current Debt has averaged $314.4 million across 4 years, with a median of $375.3 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Non-Current Debt soared 105.91% in 2022, then dropped 19.05% in 2024.
• Over 4 years, Non-Current Debt stood at $204.0 million in 2021, then soared by 83.85% to $375.1 million in 2022, then increased by 7.52% to $403.3 million in 2023, then slipped by 22.72% to $311.7 million in 2024.
• According to Business Quant data, Non-Current Debt over the past three periods registered $311.7 million, $430.6 million, and $403.3 million for Q2 2024, Q1 2024, and Q4 2023 respectively.